Аtypical McCune Albright syndrome associated with GH secreting pituitary adenoma
Journal
Endocrine Abstracts
Date Issued
2013-04
Author(s)
DOI
DOI: 10.1530/endoabs.32.P955
Abstract
McCune–Albright syndrome (MAS) is characterized by fibrous dysplasia (FD), cutaneous cafe-au-lait pigmentation and autonomous hyper-secretory endocrinopathies.
Association of acromegaly with MAS is very rare. We present a case of a 35-year-old men with MAS, diagnosed with poly-ostotic fibrous dysplasia at the age of 12, no history of premature puberty, with GH secreting cystic
macroadenoma 40!35!45 mm big and clinical picture of acromegaly, hypopituitarism and bilateral hemianopsia. FD was diagnosed based on the clinical picture, radiological findings and bone scan. Base values of the hormones were: GH 16.6 ng/ml with absent supression OGGT, IGF1 O1100 ng/ml, IGFBPZ9800 mg/ml, PRL O470 mg/ml. Our patient was treated with somatostatin analog, Octreotide 3x0.1mg for
2 months prior to transfenoidal surgery. Due to residual and activity of acromegaly, the patient was treated with external irradiation and dopamine agonist Bromergon until normal values of GH/IGF1 were achieved. One year after the surgery, FD of cranofacial bones caused fascial assymetry, ptosis of the right eyelid, strabismud, sight imparements. After Craniotomia frontotemporalis dex. Decompresion.optici dex. were performed, the symptoms disappeared. The pathohistological findings showed Osteoma (FD) of the scalp in the right occipital region. The patient is on substitution therapy with L-thyroxine, testosterone and bisphophonate.
As conclusion, primary treatment of large pituitary mass is surgery. Nonsurgical treatment, in inoperable patients due to bony involvement of the skull are somatostatin analogs, radiotherapy and dopamine agonists at maximal doses.
Association of acromegaly with MAS is very rare. We present a case of a 35-year-old men with MAS, diagnosed with poly-ostotic fibrous dysplasia at the age of 12, no history of premature puberty, with GH secreting cystic
macroadenoma 40!35!45 mm big and clinical picture of acromegaly, hypopituitarism and bilateral hemianopsia. FD was diagnosed based on the clinical picture, radiological findings and bone scan. Base values of the hormones were: GH 16.6 ng/ml with absent supression OGGT, IGF1 O1100 ng/ml, IGFBPZ9800 mg/ml, PRL O470 mg/ml. Our patient was treated with somatostatin analog, Octreotide 3x0.1mg for
2 months prior to transfenoidal surgery. Due to residual and activity of acromegaly, the patient was treated with external irradiation and dopamine agonist Bromergon until normal values of GH/IGF1 were achieved. One year after the surgery, FD of cranofacial bones caused fascial assymetry, ptosis of the right eyelid, strabismud, sight imparements. After Craniotomia frontotemporalis dex. Decompresion.optici dex. were performed, the symptoms disappeared. The pathohistological findings showed Osteoma (FD) of the scalp in the right occipital region. The patient is on substitution therapy with L-thyroxine, testosterone and bisphophonate.
As conclusion, primary treatment of large pituitary mass is surgery. Nonsurgical treatment, in inoperable patients due to bony involvement of the skull are somatostatin analogs, radiotherapy and dopamine agonists at maximal doses.
File(s)![Thumbnail Image]()
Loading...
Name
ece2013abstractbook.pdf
Size
4.31 MB
Format
Adobe PDF
Checksum
(MD5):1f39b583b69a5dc7fab6643275156b33